http://www.cnr.it/ontology/cnr/individuo/unitaDiPersonaleInterno/MATRICOLA8940
ANNALISA PINNA
- Type
- Label
- ANNALISA PINNA (literal)
- ANNALISA PINNA (literal)
- Partecipa a commessa
- Persona in rapporto
- Autore CNR di
- Caffeine consumption and Changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine. Published in Advances in psychology research (Contributo in volume (capitolo o saggio)) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1201)
- SUBCHRONIC-INTERMITTENT CAFFEINE AMPLIFIES THE MOTOR EFFECTS OF AMPHETAMINE IN RATS (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cross-sensitization between caffeine and amphetamine but not cocaine-induced locomotor behavior (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Zif-268 mRNA induction by amphetamine is increased after caffeine subchronic treatment in the rat striatum (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease (Articolo in rivista) (Prodotto della ricerca)
- New adenosine A2A antagonist: Behavioral and Biochemical characterizations as antiparkinsonian drug (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists (Articolo in rivista) (Prodotto della ricerca)
- Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('Ecstasy') in mouse brain. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Cross-sensitization between caffeine and amphetamine but not cocaine-induced locomotor behavior (Contributo in atti di convegno) (Prodotto della ricerca)
- Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independently from dopamine release (Contributo in atti di convegno) (Prodotto della ricerca)
- Sensitizzazione alla caffeina e sensitizzazione crociata all'amfetamina in ratti lesi con 6-idrossidopamina: studio comportamentale e biochimico (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Antiparkinson activity of drugs acting on D2-CB1-A2A receptors (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment (Articolo in rivista) (Prodotto della ricerca)
- Adenosine A(2A) receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- New adenosine A2A receptor antagonists: actions on Parkinson's disease models (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- A2A RECEPTORS AND INTERACTION WITH DOPAMINE SYSTEM (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- BEHAVIOURAL CHARACTERIZATION OF ENGRAILED MUTANT MICE AS MODEL OF PARKINSONS DISEASE. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ADENOSINE A2A RECEPTOR ANTAGONISTS IN PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Symptomatic efficacy of mucuna pruriens seed extract in rodent model of Parkinsons disease (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Behavioural and biochemical characterization of c-Rel mutant mice as model of Parkinsons diseas (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- DOPAMINE AND ADENOSINE RECEPTOR INTERACTION AS BASIS FOR A TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- LOCALIZING ANTIPARKINSONIAN MECHANISMS OF A2A RECEPTOR ANTAGONISTS IN BASAL GANGLIA (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- M. Morelli, N. Simola, A. Pinna, S. Pontis (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ATTENUATION OF MPTP-INDUCED NEURODEGENERATION BY NCX 2216, A NITRIC OXIDE-RELEASING DERIVATIVE OF FLURBIPROFEN (Contributo in atti di convegno) (Prodotto della ricerca)
- DOPAMINE AND ADENOSINE RECEPTOR INTERACTION AS BASIS FOR THE TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (Prodotto della ricerca)
- INTERACTION BETWEEN CAFFEINE AND DOPAMINERGIC SYSTEM (Contributo in atti di convegno) (Prodotto della ricerca)
- ADENOSINE A2A RECEPTOR ANTAGONISTS AS NEW THERAPIES FOR PARKINSONS DISEASE. SONA (Contributo in atti di convegno) (Prodotto della ricerca)
- Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat (Articolo in rivista) (Prodotto della ricerca)
- Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions (Articolo in rivista) (Prodotto della ricerca)
- EPIDEMIOLOGY OF OSTEOPOROTIC FRACTURES AND OSTEOPOROSIS-RELATED DISABLILITIES IN MEN. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Anti-epileptic and neuroprotective role of Botulinum Toxin E (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence. (Articolo in rivista) (Prodotto della ricerca)
- EVALUATION OF LOW AND HIGH DYSKINETIC POTENTIAL OF DOPAMINE AGONIST DRUGS IN THE RAT 6-OHDA MODEL OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Adenosine A(2A) receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats (Articolo in rivista) (Prodotto della ricerca)
- A new ethyladenine antagonist of adenosine A(2A) receptors: behavioural and biochemical characterization as an antiparkinsonian drug (Articolo in rivista) (Prodotto della ricerca)
- ENGRAILED MUTANT MICE AS MODEL OF PARKINSONS DISEASE: BEHAVIOURAL CHARACTERIZATION. LIMPE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- LATE-ONSET PARKINSONISM AND PREMOTOR PATHOLOGY IN NF-KB/C-REL-DEFICIENT MICE (Abstract/Poster in convegno) (Prodotto della ricerca)
- A new therapeutic strategy for Parkinson's disease (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Novel therapeutic strategy for the control of dyskinesia in the therapy of Parkinson's disease (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- L-DOPA disrupts adenosine A(2A)-cannabinoid CB1-dopamine D-2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- SENSITIZATION TO TURNING BEHAVIOUR AND ABNORMAL INVOLUNTARY MOVEMENTS IN 6-HYDROXYDOPAMINE LESIONED RATS AS MODELS OF DYSKINESIA. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- In vivo antiparkinson activity of drugs acting on A(2A)-CB1-D-2 receptors (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in adolescent mice chronically treated with 3,4-methylenedioxymethamphetamine (MDMA) (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- . Interaction between metabotropic adenosina A2A and glutamate MGLU5 receptors in parkinsonian-like muscle rigidity and tremor (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- SENSITIZATION TO TURNING BEHAVIOUR AND ABNORMAL INVOLUNTARY MOVEMENTS IN 6-HYDROXYDOPAMINE LESIONED RATS: INHFLUENCE OF THE ENVIRONMENT IN WHICH TESTS ARE PERFORMED (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ALTERED RESPONSE OF STRIATAL AND PALLIDAL NEURONS AND UNBALANCED MODULATION OF SUBSTANTIA NIGRA RETICULATA ACTIVITY MAY UNDERLIE ABNORMAL MOVEMENTS IN SUBCHRONICALLY L-DOPA TREATED RATS. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- FARMACI ANTIPARKINSONIANI ED ATTIVI IN ALTRI DISTURBI MOTORI, vol. 30 del Trattato di Farmacologia (Contributo in volume (capitolo o saggio)) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1201)
- DOPAMINE AND ADENOSINE RECEPTOR INTERACTION AS BASIS FOR THE TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Evaluation of drugs acting on CB1-A2A receptor oligomers in rat models of Parkinson's disease (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- CHRONIC INTERMITTENT TREATMENT WITH L-DOPA DIFFERENTIALLY AFFECTS ZIF268 AND GAD67 mRNA EXPRESSION IN DIRECT AND INDIRECT STRIATAL EFFERENT PATHWAYS. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Assessment of Symptomatic and Neuroprotective Efficacy of Mucuna Pruriens Seed Extract in Rodent Model of Parkinson's Disease (Articolo in rivista) (Prodotto della ricerca)
- Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D1 but not D2 receptor agonists (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Behavioral and biochemical characterization as antiparkinsonian drug of the new adenosine A2A antagonist 8-ethoxy-9-ethyladenine (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- CARATTERIZZAZIONE COMPORTAMENTALE E BIOCHIMICA DI TOPI CARENTI DELLA SUBUNITÀ C-REL DEL FATTORE NF-KB, COME MODELLO DI MALATTIA DI PARKINSON (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- EFFICACY OF RASAGILINE ON PROGRESSIVE DOPAMINE NEURON DEGENERATION AND NEUROINFLAMMATION IN A CHRONIC MPTPP MODEL OF PARKINSON'S DISEASE (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Interaction between antagonists of adenosine A2A receptors and agonists of serotonin 5-HT1A/B receptors: a novel therapeutic strategy for the control of dyskinesia in the therapy of Parkinson's disease (Contributo in atti di convegno) (Prodotto della ricerca)
- Comparative study of the influence of the acute administration of drugs of abuse on 50-kHz (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats. (Articolo in rivista) (Prodotto della ricerca)
- Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release. (Articolo in rivista) (Prodotto della ricerca)
- Blockade of A(2A) receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata (Articolo in rivista) (Prodotto della ricerca)
- Effects of adenosine A2A antagonists in the 6-OH-DA model of Parkinson's disease and clinical perspectives (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: Comparison of the effects of different psychoactive drugs and relevance in drug-induced reward (Articolo in rivista) (Prodotto della ricerca)
- REPEATED INTERMITTENT CAFFEINE POTENTIATES AMPHETAMINE-MEDIATED MOTOR STIMULANT EFFECTS AND ZIF-268 MRNA EXPRESSION IN STRIATONIGRAL NEURONS (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- RECEPTOR ANTAGONISTS IMPROVE AKINESIA AND SENSORY-MOTOR DEFICITS IN THE 6-HYDROXYDOPAMINE MODEL OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- A Critical Evaluation of Behavioral Rodent Models of Motor Impairment Used for Screening of Antiparkinsonian Activity: The Case of Adenosine A(2A) Receptor Antagonists (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice (Articolo in rivista) (Prodotto della ricerca)
- . MODEL OF DYSKINESIA IN 6-HYDROXYDOPAMINE LESIONED RATS: VALITDITY OF SENSITIZATION IN TURNING BEHAVIOUR AND ABNORMAL INVOLUNTARY MOVEMENTS (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- DIFFERENT RESPONSIVENESS OF DIRECT AND INDIRECT STRIATAL OUTPUTS NEURONS TO A CHRONIC DYSKINETIC L-DOPA TREATMENT (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ADENOSINE A2A ANTAGONISTS AND PARKINSONS DISEASE: NEW FINDINGS ON PARKINSONIAN TREMOR (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- DOPAMINE AND ADENOSINE RECEPTOR INTERACTION AS BASIS FOR THE TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- MODULATORY ROLE OF ADENOSINE A2A RECEPTORS AS BASIS FOR THE USE OF A2A ANTAGONISTS IN THE TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Late-onset parkinsonism in NF-kB/c-Rel deficient mice (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- DOPAMINE AND ADENOSINE RECEPTOR INTERACTION AS BASIS FOR THE TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ADENOSINE A2A RECEPTOR ANTAGONISTS IN THE THERAPY OF PARKINSON'S DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- MDMA ADMINISTRATION DURING ADOLESCENCE EXACERBATES MPTP-INDUCED COGNITIVE IMPAIRMENT, NEURODEGENERATION AND NEUROINFLAMMATION IN MOTOR, LIMBIC AND CORTICAL AREAS (Abstract/Poster in convegno) (Prodotto della ricerca)
- Plasticità retinica in retinite pigmentosa (Contributo in atti di convegno) (Prodotto della ricerca)
- Evaluation of drugs acting on D2-CB1-A2A receptor oligomers in rat models of Parkinson's disease (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Behavioral, Neurochemical, and Electrophysiological Changes in an Early Spontaneous Mouse Model of Nigrostriatal Degeneration (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Expression of dyskinetic movements and turning behaviour in subchronic L-DOPA 6-hydroxydopamine-treated rats is influenced by the testing environment (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- How reliable is the behavioural evaluation of dyskinesia in animal models of Parkinson's disease? (Articolo in rivista) (Prodotto della ricerca)
- Adenosine A2A receptor antagonists in Parkinson's disease: Progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Novel investigational adenosine A(2A) receptor antagonists for Parkinson's disease. (Articolo in rivista) (Prodotto della ricerca)
- ADENOSINE A2A RECEPTOR ANTAGONIST TREATMENT OF PARKINSONS DISEASE. In The basal ganglia pathophysiology: recent advances (Contributo in volume (capitolo o saggio)) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1201)
- Coautore
- Nome
- Cognome
- Afferisce a
- Ha pubblicazioni con
Incoming links:
- Autore CNR
- Plasticità retinica in retinite pigmentosa (Contributo in atti di convegno) (Prodotto della ricerca)
- DOPAMINE AND ADENOSINE RECEPTOR INTERACTION AS BASIS FOR THE TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- DIFFERENT RESPONSIVENESS OF DIRECT AND INDIRECT STRIATAL OUTPUTS NEURONS TO A CHRONIC DYSKINETIC L-DOPA TREATMENT (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ADENOSINE A2A ANTAGONISTS AND PARKINSONS DISEASE: NEW FINDINGS ON PARKINSONIAN TREMOR (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- DOPAMINE AND ADENOSINE RECEPTOR INTERACTION AS BASIS FOR THE TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ADENOSINE A2A RECEPTOR ANTAGONISTS IN THE THERAPY OF PARKINSON'S DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- MODULATORY ROLE OF ADENOSINE A2A RECEPTORS AS BASIS FOR THE USE OF A2A ANTAGONISTS IN THE TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- . MODEL OF DYSKINESIA IN 6-HYDROXYDOPAMINE LESIONED RATS: VALITDITY OF SENSITIZATION IN TURNING BEHAVIOUR AND ABNORMAL INVOLUNTARY MOVEMENTS (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- REPEATED INTERMITTENT CAFFEINE POTENTIATES AMPHETAMINE-MEDIATED MOTOR STIMULANT EFFECTS AND ZIF-268 MRNA EXPRESSION IN STRIATONIGRAL NEURONS (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- RECEPTOR ANTAGONISTS IMPROVE AKINESIA AND SENSORY-MOTOR DEFICITS IN THE 6-HYDROXYDOPAMINE MODEL OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- EVALUATION OF LOW AND HIGH DYSKINETIC POTENTIAL OF DOPAMINE AGONIST DRUGS IN THE RAT 6-OHDA MODEL OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- EPIDEMIOLOGY OF OSTEOPOROTIC FRACTURES AND OSTEOPOROSIS-RELATED DISABLILITIES IN MEN. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Anti-epileptic and neuroprotective role of Botulinum Toxin E (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ATTENUATION OF MPTP-INDUCED NEURODEGENERATION BY NCX 2216, A NITRIC OXIDE-RELEASING DERIVATIVE OF FLURBIPROFEN (Contributo in atti di convegno) (Prodotto della ricerca)
- DOPAMINE AND ADENOSINE RECEPTOR INTERACTION AS BASIS FOR THE TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (Prodotto della ricerca)
- INTERACTION BETWEEN CAFFEINE AND DOPAMINERGIC SYSTEM (Contributo in atti di convegno) (Prodotto della ricerca)
- ADENOSINE A2A RECEPTOR ANTAGONISTS AS NEW THERAPIES FOR PARKINSONS DISEASE. SONA (Contributo in atti di convegno) (Prodotto della ricerca)
- DOPAMINE AND ADENOSINE RECEPTOR INTERACTION AS BASIS FOR A TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- LOCALIZING ANTIPARKINSONIAN MECHANISMS OF A2A RECEPTOR ANTAGONISTS IN BASAL GANGLIA (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- M. Morelli, N. Simola, A. Pinna, S. Pontis (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Symptomatic efficacy of mucuna pruriens seed extract in rodent model of Parkinsons disease (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Behavioural and biochemical characterization of c-Rel mutant mice as model of Parkinsons diseas (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- BEHAVIOURAL CHARACTERIZATION OF ENGRAILED MUTANT MICE AS MODEL OF PARKINSONS DISEASE. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ADENOSINE A2A RECEPTOR ANTAGONISTS IN PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- A2A RECEPTORS AND INTERACTION WITH DOPAMINE SYSTEM (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Adenosine A(2A) receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats (Articolo in rivista) (Prodotto della ricerca)
- New adenosine A2A receptor antagonists: actions on Parkinson's disease models (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Blockade of A(2A) receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata (Articolo in rivista) (Prodotto della ricerca)
- Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release. (Articolo in rivista) (Prodotto della ricerca)
- Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D1 but not D2 receptor agonists (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- How reliable is the behavioural evaluation of dyskinesia in animal models of Parkinson's disease? (Articolo in rivista) (Prodotto della ricerca)
- Expression of dyskinetic movements and turning behaviour in subchronic L-DOPA 6-hydroxydopamine-treated rats is influenced by the testing environment (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat (Articolo in rivista) (Prodotto della ricerca)
- Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions (Articolo in rivista) (Prodotto della ricerca)
- Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats. (Articolo in rivista) (Prodotto della ricerca)
- New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists (Articolo in rivista) (Prodotto della ricerca)
- Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence. (Articolo in rivista) (Prodotto della ricerca)
- Adenosine A(2A) receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Novel investigational adenosine A(2A) receptor antagonists for Parkinson's disease. (Articolo in rivista) (Prodotto della ricerca)
- Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Behavioral, Neurochemical, and Electrophysiological Changes in an Early Spontaneous Mouse Model of Nigrostriatal Degeneration (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Past, present and future of A(2A) adenosine receptor antagonists in the therapy of Parkinson's disease (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independently from dopamine release (Contributo in atti di convegno) (Prodotto della ricerca)
- Cross-sensitization between caffeine and amphetamine but not cocaine-induced locomotor behavior (Contributo in atti di convegno) (Prodotto della ricerca)
- CHRONIC INTERMITTENT TREATMENT WITH L-DOPA DIFFERENTIALLY AFFECTS ZIF268 AND GAD67 mRNA EXPRESSION IN DIRECT AND INDIRECT STRIATAL EFFERENT PATHWAYS. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- DOPAMINE AND ADENOSINE RECEPTOR INTERACTION AS BASIS FOR THE TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ALTERED RESPONSE OF STRIATAL AND PALLIDAL NEURONS AND UNBALANCED MODULATION OF SUBSTANTIA NIGRA RETICULATA ACTIVITY MAY UNDERLIE ABNORMAL MOVEMENTS IN SUBCHRONICALLY L-DOPA TREATED RATS. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- SENSITIZATION TO TURNING BEHAVIOUR AND ABNORMAL INVOLUNTARY MOVEMENTS IN 6-HYDROXYDOPAMINE LESIONED RATS AS MODELS OF DYSKINESIA. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- . Interaction between metabotropic adenosina A2A and glutamate MGLU5 receptors in parkinsonian-like muscle rigidity and tremor (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- SENSITIZATION TO TURNING BEHAVIOUR AND ABNORMAL INVOLUNTARY MOVEMENTS IN 6-HYDROXYDOPAMINE LESIONED RATS: INHFLUENCE OF THE ENVIRONMENT IN WHICH TESTS ARE PERFORMED (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ENGRAILED MUTANT MICE AS MODEL OF PARKINSONS DISEASE: BEHAVIOURAL CHARACTERIZATION. LIMPE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Effects of adenosine A2A antagonists in the 6-OH-DA model of Parkinson's disease and clinical perspectives (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Sensitizzazione alla caffeina e sensitizzazione crociata all'amfetamina in ratti lesi con 6-idrossidopamina: studio comportamentale e biochimico (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- New adenosine A2A antagonist: Behavioral and Biochemical characterizations as antiparkinsonian drug (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Cross-sensitization between caffeine and amphetamine but not cocaine-induced locomotor behavior (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Zif-268 mRNA induction by amphetamine is increased after caffeine subchronic treatment in the rat striatum (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- ADENOSINE A2A RECEPTOR ANTAGONIST TREATMENT OF PARKINSONS DISEASE. In The basal ganglia pathophysiology: recent advances (Contributo in volume (capitolo o saggio)) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1201)
- Caffeine consumption and Changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine. Published in Advances in psychology research (Contributo in volume (capitolo o saggio)) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1201)
- FARMACI ANTIPARKINSONIANI ED ATTIVI IN ALTRI DISTURBI MOTORI, vol. 30 del Trattato di Farmacologia (Contributo in volume (capitolo o saggio)) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1201)
- A new ethyladenine antagonist of adenosine A(2A) receptors: behavioural and biochemical characterization as an antiparkinsonian drug (Articolo in rivista) (Prodotto della ricerca)
- Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: Comparison of the effects of different psychoactive drugs and relevance in drug-induced reward (Articolo in rivista) (Prodotto della ricerca)
- Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment (Articolo in rivista) (Prodotto della ricerca)
- Assessment of Symptomatic and Neuroprotective Efficacy of Mucuna Pruriens Seed Extract in Rodent Model of Parkinson's Disease (Articolo in rivista) (Prodotto della ricerca)
- Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('Ecstasy') in mouse brain. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice (Articolo in rivista) (Prodotto della ricerca)
- SUBCHRONIC-INTERMITTENT CAFFEINE AMPLIFIES THE MOTOR EFFECTS OF AMPHETAMINE IN RATS (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- L-DOPA disrupts adenosine A(2A)-cannabinoid CB1-dopamine D-2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Adenosine A2A receptor antagonists in Parkinson's disease: Progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Antiparkinson activity of drugs acting on D2-CB1-A2A receptors (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Evaluation of drugs acting on CB1-A2A receptor oligomers in rat models of Parkinson's disease (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- In vivo antiparkinson activity of drugs acting on A(2A)-CB1-D-2 receptors (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in adolescent mice chronically treated with 3,4-methylenedioxymethamphetamine (MDMA) (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- A new therapeutic strategy for Parkinson's disease (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Novel therapeutic strategy for the control of dyskinesia in the therapy of Parkinson's disease (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- LATE-ONSET PARKINSONISM AND PREMOTOR PATHOLOGY IN NF-KB/C-REL-DEFICIENT MICE (Abstract/Poster in convegno) (Prodotto della ricerca)
- Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease (Articolo in rivista) (Prodotto della ricerca)
- A Critical Evaluation of Behavioral Rodent Models of Motor Impairment Used for Screening of Antiparkinsonian Activity: The Case of Adenosine A(2A) Receptor Antagonists (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Evaluation of drugs acting on D2-CB1-A2A receptor oligomers in rat models of Parkinson's disease (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Late-onset parkinsonism in NF-kB/c-Rel deficient mice (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- MDMA ADMINISTRATION DURING ADOLESCENCE EXACERBATES MPTP-INDUCED COGNITIVE IMPAIRMENT, NEURODEGENERATION AND NEUROINFLAMMATION IN MOTOR, LIMBIC AND CORTICAL AREAS (Abstract/Poster in convegno) (Prodotto della ricerca)
- Comparative study of the influence of the acute administration of drugs of abuse on 50-kHz (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Interaction between antagonists of adenosine A2A receptors and agonists of serotonin 5-HT1A/B receptors: a novel therapeutic strategy for the control of dyskinesia in the therapy of Parkinson's disease (Contributo in atti di convegno) (Prodotto della ricerca)
- EFFICACY OF RASAGILINE ON PROGRESSIVE DOPAMINE NEURON DEGENERATION AND NEUROINFLAMMATION IN A CHRONIC MPTPP MODEL OF PARKINSON'S DISEASE (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Behavioral and biochemical characterization as antiparkinsonian drug of the new adenosine A2A antagonist 8-ethoxy-9-ethyladenine (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- CARATTERIZZAZIONE COMPORTAMENTALE E BIOCHIMICA DI TOPI CARENTI DELLA SUBUNITÀ C-REL DEL FATTORE NF-KB, COME MODELLO DI MALATTIA DI PARKINSON (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- Coautore
- Ha pubblicazioni con
- Partecipazione di
- Ha afferente
- Rapporto con persona